Drugs / Mitox
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT06084819 Comparator | Aug 2023 → Jan 2029 expected | acute myeloid leukemia | Chinese PLA General Hospital | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mitox | “Mitox(10mg/m2,days 1 to 5)” NCT06084819 ↗ |